ABSTRACT
Consumption of edible oils contaminated with Argemone oil (AO) leads to a clinical condition called "Epidemic dropsy". Earlier studies have reported that metabolism and oxidative stress primarily contributes to AO toxicity, however, the involvement of immune system has not been assessed so far. Therefore, the present study was undertaken to systematically assess the effect of AO exposure on the function of immune system in Balb/c mice. The repeated exposure of AO for 28 days caused prominent regression of spleen and thymus; severe inflammatory changes in spleen depicted by the loss of distinct follicles, increased megakaryocyte infiltration, and enhanced expression levels of inflammatory markers (iNOS & COX-2). At the functional level, AO exposure significantly abrogated the mixed lymphocyte reaction and mitogen-stimulated lymphoproliferative activity of T and B cells, which is reflective of profound lymphocyte dysfunction upon antigen exposure. In concordance with the loss in functional activity of lymphocytes in AO exposed animals, it was found the AO altered the relative percentage of CD3+, CD4+, and CD28â¯+â¯T cells. Further, there was a marked decrease in the relative distribution of cells with prominent MHC I and CD1d expression in AO exposed splenocytes. Moreover, reduced levels of immune stimulatory cytokines (TNF-α, IFN-γ, IL-2, IL-4, and IL-6), and increased levels of immunosuppressive cytokine IL-10 were detected in the serum of AO treated mice. Along with T and B cells, AO exposure also affected the phenotype and activation status of macrophages suggesting the inclination towards "alternative activation of macrophages". Altogether, these functional changes in the immune cells are contributing factors in AO induced immunosuppression.
Subject(s)
Immune Tolerance/drug effects , Plant Oils/toxicity , Spleen/drug effects , Thymus Gland/drug effects , Administration, Oral , Animals , Antigens, CD1d/metabolism , B-Lymphocytes/cytology , B-Lymphocytes/drug effects , B-Lymphocytes/metabolism , Cell Proliferation/drug effects , Cyclooxygenase 2/metabolism , Female , Flow Cytometry , Interleukins/blood , Intestines/pathology , Mice , Mice, Inbred BALB C , Nitric Oxide Synthase Type II/metabolism , Organ Size/drug effects , Spleen/metabolism , Spleen/pathology , T-Lymphocytes/cytology , T-Lymphocytes/drug effects , T-Lymphocytes/metabolism , Thymus Gland/metabolism , Thymus Gland/pathology , Tumor Necrosis Factor-alpha/bloodABSTRACT
AIMS: Uprising reports towards deltamethrin (DLM)-induced toxicity in non-target species including mammals have raised a worldwide concern. Moreover, in the absence of any identified marker, the prediction of DLM elicited early toxic manifestations in non-targets remains elusive. MAIN METHODS: Comprehensive approach of proteome profiling along with conventional toxico-physiological correlation analysis was performed to classify novel protein based markers in the plasma of DLM exposed Wistar rats. Animals were exposed orally to DLM (low dose: 2.56mg/kg b.wt. and high dose: 5.12mg/kg b.wt.) up to seven consecutive days. KEY FINDINGS: The UPLC-MS/MS analysis revealed a dose-dependent dissemination of DLM and its primary metabolite (3-Phenoxy benzoic acid) in rat plasma. Through 2-DE-MS/MS plasma profiling and subsequent verification at the transcriptional level, we found that 6 liver emanated acute phase proteins (Apolipoprotein-AIV, Apolipoprotein E, Haptoglobin, Hemopexin, Vitamin D Binding protein, and Fibrinogen gamma chain) were significantly (p<0.05) modulated in DLM treated groups in a dose-dependent manner. Accordingly, DLM exposure resulted in adverse effects on body growth (body weight & relative organ weight), serum profile, liver function and histology, inflammatory changes (enhanced TNF-É, TGF-ß and IL6 level), and oxidative stress. Moreover, these toxic manifestations were suppressed upon N-acetyl cysteine (NAC) supplementation in DLM treated animals. Thus, DLM-induced inflammatory response and subsequent oxidative injury to liver grounds the altered expression of identified acute phase proteins. SIGNIFICANCE: In conclusion, we proposed these six liver emanated plasma proteins as novel candidate markers to assess the early DLM-induced hepatotoxicity in non-target species with a minimal invasive mean.
Subject(s)
Blood Proteins/metabolism , Liver/drug effects , Nitriles/toxicity , Pesticides/toxicity , Pyrethrins/toxicity , Animals , Male , Rats , Rats, WistarABSTRACT
Our previous studies indicated that zinc oxide nanoparticles (ZnO NPs) have adjuvant properties to a known allergen ovalbumin (OVA) in Balb/c mice. Therefore, in this study, we focused on the mechanisms involved in adjuvant responses induced by ZnO NPs. The eosinophil counts in the Peyers' patches of intestine and ICAM-1, Cox2 protein expressions were enhanced in the ZnO NPs/OVA group. Following screening of toll-like receptors (TLRs), TLR 2, 4 and 6 were found to be increased. Accordingly, we found that downstream proteins of TLRs such as myeloid differentiation primary response protein-88 (MyD88), IL-1 receptor associated kinase 1 (IRAK 1), and TNFR-associated factor 6 (TRAF 6) were also found to be enhanced in the ZnO NPs/OVA-induced group. These inflammatory responses underlined the critical roles of TLRs in the inflammatory response. ZnO NPs increased the mRNA levels of inflammatory cytokine IL-1ß and protein expression of several mediators, including Cox2, PGE2, MMP-9 and finally caspase 1 in macrophages. Another pathway for adjuvant effect is Src which was found to be significantly affected by the activation of p-Lyn, p-Syk, IP3, p-PLC-γ and cAMP. Ca(2+) influx was significantly increased as well in the ZnO NPs/OVA group. These findings demonstrated the differential role of TLRs in regulation of the ZnO NPs-induced adjuvant responses causing the inflammation. We therefore, conclude that ZnO NPs have significant adjuvant effect via following Src kinase and TLRs signaling that ascribed to inflammatory responses due to recruitment and activation of adhesion molecules and inflammatory cells. The adjuvant property of ZnO NPs may help in planning strategies for its therapeutic use.
Subject(s)
Adjuvants, Immunologic/pharmacology , Nanoparticles/chemistry , Signal Transduction , Toll-Like Receptors/metabolism , Zinc Oxide/pharmacology , src-Family Kinases/metabolism , Animals , Caspase 1/metabolism , Cyclooxygenase 2/metabolism , Female , Inflammation/immunology , Intercellular Adhesion Molecule-1/metabolism , Interleukin-1 Receptor-Associated Kinases/metabolism , Interleukin-1beta/metabolism , Intestinal Mucosa/metabolism , Intestines/drug effects , Macrophages/metabolism , Mice , Mice, Inbred BALB C , Myeloid Differentiation Factor 88/metabolism , Ovalbumin/immunology , RNA, Messenger/metabolism , TNF Receptor-Associated Factor 6/metabolism , Toll-Like Receptor 2/metabolism , Toll-Like Receptor 4/metabolism , Toll-Like Receptor 6/metabolism , Zinc Oxide/chemistryABSTRACT
Zinc oxide nanoparticles (ZNPs) have been used in dietary supplements and may cause an immunomodulatory effect. The present study investigated the effect of ZNPs on antigen-specific immune responses in mice sensitized with the T-cell-dependent antigen ovalbumin (OVA). BALB/c mice were intraperitoneally administered ZNPs (0.25, 0.5, 1 and 3mg) once, in combination with OVA, and the serum antibodies, splenocyte reactivity and activation of antigen-presenting cells were examined. The serum levels of OVA-specific IgG1 and IgE were found significantly enhanced by treatment with ZNPs over control. An increased level of IL-2, IL-4, IL-6, IL-17 and decreased level of IL-10 and TNF-α in splenocytes administered with ZNPs were observed in comparison with control. The ZNPs and OVA-stimulated T lymphocytes showed enhanced proliferation compared with control. Macrophages and B cells showed high expression of MHC class II, whereas higher expression of CD11b in macrophages of the ZNPs and ZNPs/OVA treated groups was observed. The lungs and spleen had increased eosinophils and mast cell numbers. Also, myeloperoxidase activity in lungs was found to be increased by 2.5-fold in the case of ZNPs and 3.75-fold increase in ZNPs/OVA, whereas in intestine, there was significant increase in both the groups. Increased expression of the genes for GATA-3, SOCS-3, TLR-4, IL-13 and IL-5 in the intestine was observed. Collectively, these data indicate that systemic exposure to a single administration of ZNPs could enhance subsequent antigen-specific immune reactions, including the serum production of antigen-specific antibodies, and the functionality of T cells.
Subject(s)
Adjuvants, Immunologic/administration & dosage , B-Lymphocytes/immunology , Cytokines/biosynthesis , Immunoglobulin E/biosynthesis , Immunoglobulin G/biosynthesis , Macrophages/immunology , Metal Nanoparticles/administration & dosage , Th2 Cells/immunology , Animals , Cell Differentiation/drug effects , Cell Proliferation/drug effects , Cells, Cultured , Cytokines/blood , Cytokines/genetics , Dietary Supplements/adverse effects , Female , GATA3 Transcription Factor/genetics , GATA3 Transcription Factor/metabolism , Humans , Immunoglobulin E/blood , Immunoglobulin E/genetics , Immunoglobulin G/blood , Immunoglobulin G/genetics , Lymphocyte Activation/drug effects , Metal Nanoparticles/adverse effects , Metal Nanoparticles/chemistry , Mice , Mice, Inbred BALB C , Ovalbumin/immunology , Suppressor of Cytokine Signaling 3 Protein , Suppressor of Cytokine Signaling Proteins/genetics , Suppressor of Cytokine Signaling Proteins/metabolism , Up-Regulation/drug effects , Zinc Oxide/chemistryABSTRACT
BACKGROUND AND OBJECTIVES: Though increased emphasis is being given to expanding dental care facilities and awareness in Indian villages, the target population is unfortunately less literate and financially-equipped compared to their urban counterparts. This study attempted to evaluate dental myths, oral hygiene methods and beliefs, and tobacco habits present in a rural ageing population. MATERIAL AND METHODS: The study area consisted of a group of 10 villages, situated in the district of Lucknow, Uttar Pradesh, India. The sample comprised 681 people aged 50 years or above. The subjects were questioned about dental myths, tobacco habits and oral hygiene methods and then divided into groups on the basis of age, gender, and educational status. Mean values, standard deviation, chi-square test, t-test and p values were used to obtain inter-group comparisons. RESULTS: Forty percent of the subjects considered oral hygiene unnecessary, with 61% relying on simple mouth rinsing for maintaining oral hygiene, 48% either smoked and chewed tobacco or both and 81% had one or more dental myth. CONCLUSION: The results showed that the rural ageing population is deprived and a targeted programme to spread scientific dental practices to them is necessary.